1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generics in South Africa

Generics in South Africa

  • January 2016
  • -
  • MarketLine
  • -
  • 36 pages

Introduction

Generics in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

- The South African generics market is expected to generate total revenues of $729m in 2015, representing a compound annual growth rate (CAGR) of 9% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 76.3% of total pharma volume in 2015.

- The government is showing strong support for generic drugs in Africa, which should see good growth in the future. For example, pharmacists are required by law to inform private patients about generic alternatives.

Features

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in South Africa

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Africa

- Leading company profiles reveal details of key generics market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the South Africa generics market with five year forecasts by both value and volume

- Macroeconomic indicators provide insight into general trends within the South Africa economy

Key Questions Answered

- What was the size of the South Africa generics market by value in 2015?

- What will be the size of the South Africa generics market in 2020?

- What factors are affecting the strength of competition in the South Africa generics market?

- How has the market performed over the last five years?

- How large is South Africa’s generics market in relation to its regional counterparts?

Table Of Contents

Generics in South Africa
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market volume 10
Market Segmentation 11
Geography segmentation 11
Market Outlook 12
Market value forecast 12
Market volume forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Adcock Ingram Holdings Limited 20
Aspen Pharmacare Holdings Ltd 24
Teva Pharmaceutical Industries Limited 28
Macroeconomic Indicators 31
Country Data 31
Methodology 33
Industry associations 34
Related MarketLine research 34
Appendix 35
About MarketLine 35

List of Tables
Table 1: South Africa generics market value: $ million, 2011-15(e)
Table 2: South Africa generics market volume: % of total pharma volume, 2011-15(e)
Table 3: South Africa generics market geography segmentation: $ billion, 2015(e)
Table 4: South Africa generics market value forecast: $ million, 2015-20
Table 5: South Africa generics market volume forecast: % of total pharma volume, 2015-20
Table 6: Adcock Ingram Holdings Limited: key facts
Table 7: Adcock Ingram Holdings Limited: key financials ($)
Table 8: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 9: Adcock Ingram Holdings Limited: key financial ratios
Table 10: Aspen Pharmacare Holdings Ltd: key facts
Table 11: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 12: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 13: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 14: Teva Pharmaceutical Industries Limited: key facts
Table 15: Teva Pharmaceutical Industries Limited: key financials ($)
Table 16: Teva Pharmaceutical Industries Limited: key financial ratios
Table 17: South Africa size of population (million), 2011-15
Table 18: South Africa gdp (constant 2005 prices, $ billion), 2011-15
Table 19: South Africa gdp (current prices, $ billion), 2011-15
Table 20: South Africa inflation, 2011-15
Table 21: South Africa consumer price index (absolute), 2011-15
Table 22: South Africa exchange rate, 2011-15

List of Figures
Figure 1: South Africa generics market value: $ million, 2011-15(e)
Figure 2: South Africa generics market volume: % of total pharma volume, 2011-15(e)
Figure 3: South Africa generics market geography segmentation: % share, by value, 2015(e)
Figure 4: South Africa generics market value forecast: $ million, 2015-20
Figure 5: South Africa generics market volume forecast: % of total pharma volume, 2015-20
Figure 6: Forces driving competition in the generics market in South Africa, 2015
Figure 7: Drivers of buyer power in the generics market in South Africa, 2015
Figure 8: Drivers of supplier power in the generics market in South Africa, 2015
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2015
Figure 10: Factors influencing the threat of substitutes in the generics market in South Africa, 2015
Figure 11: Drivers of degree of rivalry in the generics market in South Africa, 2015
Figure 12: Adcock Ingram Holdings Limited: revenues and profitability
Figure 13: Adcock Ingram Holdings Limited: assets and liabilities
Figure 14: Aspen Pharmacare Holdings Ltd: revenues and profitability
Figure 15: Aspen Pharmacare Holdings Ltd: assets and liabilities
Figure 16: Teva Pharmaceutical Industries Limited: revenues and profitability
Figure 17: Teva Pharmaceutical Industries Limited: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.